Kim, M.; Lee, Y.J.; Seon, K.E.; Kim, S.; Lee, C.; Park, H.; Choi, M.C.; Lee, J.-Y.
Morbidity and Mortality Outcomes After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Treatment of Ovarian Cancer. J. Clin. Med. 2025, 14, 1782.
https://doi.org/10.3390/jcm14051782
AMA Style
Kim M, Lee YJ, Seon KE, Kim S, Lee C, Park H, Choi MC, Lee J-Y.
Morbidity and Mortality Outcomes After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Treatment of Ovarian Cancer. Journal of Clinical Medicine. 2025; 14(5):1782.
https://doi.org/10.3390/jcm14051782
Chicago/Turabian Style
Kim, Migang, Yong Jae Lee, Ki Eun Seon, Sunghoon Kim, Chan Lee, Hyun Park, Min Chul Choi, and Jung-Yun Lee.
2025. "Morbidity and Mortality Outcomes After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Treatment of Ovarian Cancer" Journal of Clinical Medicine 14, no. 5: 1782.
https://doi.org/10.3390/jcm14051782
APA Style
Kim, M., Lee, Y. J., Seon, K. E., Kim, S., Lee, C., Park, H., Choi, M. C., & Lee, J.-Y.
(2025). Morbidity and Mortality Outcomes After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Treatment of Ovarian Cancer. Journal of Clinical Medicine, 14(5), 1782.
https://doi.org/10.3390/jcm14051782
